#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Antithrombin III deficiency Osteosarcoma metastatic Biliary cancer metastatic Cholangiosarcoma Pulmonary arterial hypertension Mixed-type liposarcoma Blastic plasmacytoid dendritic cell neoplasia Progressive multifocal leukoencephalopathy Mitochondrial encephalomyopathy Colon cancer Non-Hodgkin's lymphoma unspecified histology indolent Mantle cell lymphoma stage III Essential thrombocythaemia Drug eruption Cutaneous T-cell lymphoma stage II More trials…

    Learn about Rare Diseases

    Primary immunodeficiency syndrome Fabry’s disease Prolymphocytic leukaemia – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Nodal marginal zone B-cell lymphoma Angiosarcoma non-metastatic – Life with Disease Kearns-Sayre syndrome Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Primary mediastinal large B-cell lymphoma – Trials in Disease Focal segmental glomerulosclerosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tebentafusp Gns561 Acoramidis Hydrochloride Amivantamab AZD0120 Pimozide Zinc Oxide Fluorescein Sodium Piritramide Perindopril Tert-Butylamine Desloratadine Tiotropium Bromide Monohydrate Epinephrine Hydrochloride Mirodenafil Dihydrochloride Corylus Avellana L. Bexotegrast Chlorpromazine Hydrochloride Gen3017 Deferoxamine Mesilate Atenolol More therapies…

    Learn about Your Condition

    Hypertriglyceridaemia Myotonia Adenosquamous cell lung cancer Thymic carcinoma Myxofibrosarcoma Prinzmetal angina Methylmalonic acidaemia Uterine leiomyosarcoma Immunodeficiency Sleep disorder Fibromyalgia Extra-osseous Ewing's sarcoma Peptostreptococcus infection Labour pain Epiphysiolysis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immune system processes

  • Study on Optimizing Ravulizumab Dosing for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Paroxysmal nocturnal haemoglobinuria
    Investigated Drugs:
    • Ravulizumab
    The Netherlands

  • Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Anifrolumab
    Austria Belgium Bulgaria Czechia Denmark France +7

  • Study on Rituximab for Achieving Remission in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Rituximab
    The Netherlands

  • Study on Extracellular Vesicles in Hematology Patients Treated with Brexucabtagene Autoleucel and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Lymphocyte adoptive therapy
    Investigated Drugs:
    • Brexucabtagene Autoleucel
    • Axicabtagene Ciloleucel
    • Gadobutrol
    France

  • Study on the Safety and Immune Response of Shingrix Vaccine in Patients with Psoriasis or Psoriatic Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    • Psoriatic arthropathy
    Investigated Drugs:
    • Recombinant Varicella Zoster Virus Glycoprotein E
    Germany

  • Comparison of hydrocortisone and dexamethasone eye drops for treating inflammatory conjunctival secretions in patients with ocular prostheses

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Povidone
    • Hydrocortisone Sodium Phosphate
    • Dexamethasone Phosphate
    France
Previous Page
1 2 3 4 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!